Litcius/Paper detail

Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022

Tara C. Anderson, Nina B. Masters, Angela Guo, Leah Shepersky, Andrew J. Leidner, Grace M. Lee, Camille N. Kotton, Kathleen Dooling

2022American Journal of Transplantation17 citationsDOI

Topics & Concepts

MedicineAdvisory committeeImmunizationIncidence (geometry)PediatricsImmunologyFamily medicineImmune systemPhysicsPolitical scienceOpticsPublic administrationHerpesvirus Infections and TreatmentsAcne and Rosacea Treatments and EffectsRabies epidemiology and control
Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022 | Litcius